FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michele Morari

Research Profile

Living Beings

Chemicals & Drugs

Procedures

Microdialysis

Anatomy

Co-author Network

Publications

TOP 3
M Marti; Flora Mela; S Molinari; Paola Petrillo; Silvio Ronzoni; M Volta; N T Zaveri; M Budri; Girolamo Calò; D Malfacini; Michele Morari
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111.
Matteo Marti; Erwan Bezard; Riccardo Brambilla; Paolo Calabresi; Stefania Fasano; Remo Guerrini; Qin Li; Ilaria Morella; Donata Rodi; Michele Simonato; Alessandro Tozzi; Michele Morari
Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias.
Andrea Buzzi; Maia Chikhladze; Chiara Falcicchia; Silvana Franceschetti; Giovanni Lanza; Matteo Marti; Michele Morari; Beatrice Paradiso; Marie Soukupova; Michele Simonato
Loss of cortical GABA terminals in Unverricht-Lundborg disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michele Morari (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: M Marti; Flora Mela; S Molinari; Paola Petrillo; Silvio Ronzoni; M Volta; N T Zaveri; M Budri; Girolamo Calò; D Malfacini; Michele Morari
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111.
British journal of pharmacology 2013;168(4):863-79.
2012: Matteo Marti; Erwan Bezard; Riccardo Brambilla; Paolo Calabresi; Stefania Fasano; Remo Guerrini; Qin Li; Ilaria Morella; Donata Rodi; Michele Simonato; Alessandro Tozzi; Michele Morari
Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012;32(46):16106-19.
2012: Andrea Buzzi; Maia Chikhladze; Chiara Falcicchia; Silvana Franceschetti; Giovanni Lanza; Matteo Marti; Michele Morari; Beatrice Paradiso; Marie Soukupova; Michele Simonato
Loss of cortical GABA terminals in Unverricht-Lundborg disease.
Neurobiology of disease 2012;47(2):216-24.
2012: Michele Morari
L-dopa impairs proteasome activity in Parkinsonism through D1 dopamine receptor.
Movement disorders : official journal of the Movement Disorder Society 2012;27(6):706.
2012: Elisabetta Esposito; Paolo Mariani; Serena Mazzoni; Enea Menegatti; Michele Morari; Laura Ravani; Mattia Volta; Simone Bido; Catia Contado; Markus Drechsler; Rita Cortesi
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2012;80(2):306-14.
2012: Flora Mela; Simone Bido; M Angela Cenci; Matteo Marti; Michele Morari
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
Neurobiology of disease 2012;45(1):573-82.
2011: Simone Bido; Matteo Marti; Michele Morari
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels.
Journal of neurochemistry 2011;118(6):1043-55.
2011: Martina Fantin; Michele Morari; François Tison; Pierre-Olivier Fernagut
NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid.
Neurological research 2011;33(4):444-7.
2011: Riccardo Viaro; Michele Morari; Gianfranco Franchi
Progressive motor cortex functional reorganization following 6-hydroxydopamine lesioning in rats.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(12):4544-54.
2011: Mattia Volta; Riccardo Viaro; Claudio Trapella; Matteo Marti; Michele Morari
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity.
Experimental neurology 2011;228(1):126-37.
2010: Mattia Volta; Omar S Mabrouk; Simone Bido; Matteo Marti; Michele Morari
Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice.
Journal of neurochemistry 2010;115(6):1543-55.
2010: Matteo Marti; Silvio Sarubbo; Francesco Latini; Michele Cavallo; Roberto Eleopra; Sara Biguzzi; Christian Lettieri; Carlo Conti; Michele Simonato; Silvia Zucchini; Rocco Quatrale; Mariachiara Sensi; Sanzio Candeletti; Patrizia Romualdi; Michele Morari
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2010;25(11):1723-32.
2010: Mattia Volta; Matteo Marti; John McDonald; Stefano Molinari; Valeria Camarda; Michela Pelà; Claudio Trapella; Michele Morari
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4).
Peptides 2010;31(6):1194-204.
2010: Riccardo Viaro; Matteo Marti; Michele Morari
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
Experimental neurology 2010;223(2):473-84.
2010: O S Mabrouk; Matteo Marti; Michele Morari
Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
Neuroscience 2010;166(1):40-8.
2010: Flora Mela; Mark J Millan; Mauricette Brocco; Michele Morari
The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats.
Neuropharmacology 2010;58(2):528-36.
2009: O S Mabrouk; Matteo Marti; Severo Salvadori; Michele Morari
The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.
Neuroscience 2009;164(2):360-9.
2008: Martina Fantin; Yves P Auberson; Michele Morari
Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.
Journal of neurochemistry 2008;106(2):957-68.
2008: Elisabetta Esposito; Martina Fantin; Matteo Marti; Markus Drechsler; Lydia Paccamiccio; Paolo Mariani; Elisa Sivieri; Francesco Lain; Enea Menegatti; Michele Morari; Rita Cortesi
Solid lipid nanoparticles as delivery systems for bromocriptine.
Pharmaceutical research 2008;25(7):1521-30.
2008: Riccardo Viaro; Rosario Sanchez-Pernaute; Matteo Marti; Claudio Trapella; Ole Isacson; Michele Morari
Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism.
Neurobiology of disease 2008;30(3):430-8.
2007: Martina Fantin; Matteo Marti; Yves P Auberson; Michele Morari
NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
Journal of neurochemistry 2007;103(6):2200-11.
2007: Martina Fantin; Carmela Fischetti; Claudio Trapella; Michele Morari
Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.
British journal of pharmacology 2007;152(4):549-55.
2007: Barbara Spagnolo; Giacomo Carrà; Martina Fantin; Carmela Fischetti; Christopher P Hebbes; John McDonald; Timothy A Barnes; Anna Rizzi; Claudio Trapella; Giulia Fanton; Michele Morari; David G Lambert; Domenico Regoli; Girolamo Calò
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
The Journal of pharmacology and experimental therapeutics 2007;321(3):961-7.
2007: Flora Mela; Matteo Marti; Andrzej Dekundy; Wojciech Danysz; Michele Morari; M Angela Cenci
Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
Journal of neurochemistry 2007;101(2):483-97.
2007: Matteo Marti; Claudio Trapella; Riccardo Viaro; Michele Morari
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(6):1297-307.
2006: Flora Mela; Matteo Marti; Chiara Fiorentini; Cristina Missale; Michele Morari
Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine.
Molecular and cellular neurosciences 2006;31(2):284-92.
2005: Matteo Marti; Flora Mela; Martina Fantin; Silvia Zucchini; Jeffrey M Brown; Jassir Witta; Manuela Di Benedetto; Beata Buzas; Rainer K Reinscheid; Severo Salvadori; Remo Guerrini; Patrizia Romualdi; Sanzio Candeletti; Michele Simonato; Brian M Cox; Michele Morari
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(42):9591-601.
2005: Matteo Marti; Massimiliano Manzalini; Martina Fantin; Clementina Bianchi; Laura Della Corte; Michele Morari
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Journal of neurochemistry 2005;93(1):195-205.
2005: Giacomo Carrà; Anna Rizzi; Remo Guerrini; Timothy A Barnes; John McDonald; Christopher P Hebbes; Flora Mela; Velga A Kenigs; Giuliano Marzola; Daniela Rizzi; Elaine Gavioli; Silvia Zucchini; Domenico Regoli; Michele Morari; Severo Salvadori; David J Rowbotham; David G Lambert; Daniel R Kapusta; Girolamo Calo'
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
The Journal of pharmacology and experimental therapeutics 2005;312(3):1114-23.
2004: Matteo Marti; Flora Mela; Remo Guerrini; Girolamo Calò; Clementina Bianchi; Michele Morari
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release.
Journal of neurochemistry 2004;91(6):1501-4.
2004: Matteo Marti; Flora Mela; Carlo Veronesi; Remo Guerrini; Severo Salvadori; Mauro Federici; Nicola B Mercuri; Anna Rizzi; Gianfranco Franchi; Lorenzo Beani; Clementina Bianchi; Michele Morari
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(30):6659-66.
2004: Flora Mela; Matteo Marti; Linda Ulazzi; Elvis Vaccari; Silvia Zucchini; Claudio Trapella; Severo Salvadori; Lorenzo Beani; Clementina Bianchi; Michele Morari
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
The European journal of neuroscience 2004;19(5):1317-24.
2004: Emilia Saulle; Paolo Gubellini; Barbara Picconi; Diego Centonze; Domenicantonio Tropepi; Antonio Pisani; Michele Morari; Matteo Marti; Luisa Rossi; MICHELE PAPA; Giorgio Bernardi; Paolo Calabresi
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease.
Molecular and cellular neurosciences 2004;25(1):9-20.
2003: Matteo Marti; Flora Mela; Linda Ulazzi; Stefania Hanau; Sara Stocchi; Francesca Paganini; Lorenzo Beani; Clementina Bianchi; Michele Morari
Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington's disease.
The European journal of neuroscience 2003;18(4):759-67.
2003: Matteo Marti; Francesca Paganini; Sara Stocchi; Flora Mela; Lorenzo Beani; Clementina Bianchi; Michele Morari
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors.
Journal of neurochemistry 2003;84(4):792-802.
2003: Matteo Marti; Sara Stocchi; Francesca Paganini; Flora Mela; Carmela De Risi; Girolamo Calo'; Remo Guerrini; Timothy A Barnes; David G Lambert; Lorenzo Beani; Clementina Bianchi; Michele Morari
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
British journal of pharmacology 2003;138(1):91-8.
2002: Matteo Marti; Flora Mela; Clementina Bianchi; Lorenzo Beani; Michele Morari
Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
Journal of neurochemistry 2002;83(3):635-44.
2002: Anna Siniscalchi; Donata Rodi; Michele Morari; Matteo Marti; Sabrina Cavallini; Silvia Marino; Lorenzo Beani; Clementina Bianchi
Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro.
British journal of pharmacology 2002;136(8):1178-84.
2002: Antonio Pisani; Paola Bonsi; Maria Vincenza Catania; Raffaella Giuffrida; Michele Morari; Matteo Marti; Diego Centonze; Giorgio Bernardi; Ann E Kingston; Paolo Calabresi
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(14):6176-85.
2002: Girolamo Calo; Anna Rizzi; Daniela Rizzi; Raffaella Bigoni; Remo Guerrini; Giuliano Marzola; Matteo Marti; John McDonald; Michele Morari; David G Lambert; Severo Salvadori; Domenico Regoli
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
British journal of pharmacology 2002;136(2):303-11.
2002: Matteo Marti; Remo Guerrini; Lorenzo Beani; Clementina Bianchi; Michele Morari
Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat.
Neuroscience 2002;112(1):153-60.
2001: Matteo Marti; Francesca Paganini; Sara Stocchi; Clementina Bianchi; Lorenzo Beani; Michele Morari
Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release.
The European journal of neuroscience 2001;14(7):1181-4.
2000: M Marti; Gianni Bregola; Michele Morari; A Gemignani; Michele Simonato
Somatostatin release in the hippocampus in the kindling model of epilepsy: a microdialysis study.
Journal of neurochemistry 2000;74(6):2497-503.
2000: S Sbrenna; Matteo Marti; Michele Morari; Girolamo Calo'; Remo Guerrini; Lorenzo Beani; Clementina Bianchi
Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.
British journal of pharmacology 2000;130(2):425-33.
2000: Matteo Marti; S Sbrenna; Kjell Fuxe; Clementina Bianchi; Lorenzo Beani; Michele Morari
Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats.
The European journal of neuroscience 2000;12(5):1848-50.
1999: S Sbrenna; Matteo Marti; Michele Morari; Girolamo Calo; Remo Guerrini; Lorenzo Beani; Clementina Bianchi
L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1365-71.
1999: Matteo Marti; S Sbrenna; Kjell Fuxe; Clementina Bianchi; Lorenzo Beani; Michele Morari
In vitro evidence for increased facilitation of striatal acetylcholine release via pre- and postsynaptic NMDA receptors in hemiparkinsonian rats.
Journal of neurochemistry 1999;72(2):875-8.
1998: Michele Morari; Matteo Marti; S Sbrenna; Kjell Fuxe; Clementina Bianchi; Lorenzo Beani
Reciprocal dopamine-glutamate modulation of release in the basal ganglia.
Neurochemistry international 1998;33(5):383-97.
1998: Michele Morari; S Sbrenna; Matteo Marti; F Caliari; Clementina Bianchi; Lorenzo Beani
NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms.
Journal of neurochemistry 1998;71(5):2006-17.
1998: Michele Morari; S Sbrenna; Matteo Marti; WT O'Connor; Clementina Bianchi; Kjell Fuxe; Lorenzo Beani
Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat.
The European journal of neuroscience 1998;10(5):1716-22.
1996: Michele Morari; WT O'Connor; U Ungerstedt; C Bianchi; Kjell Fuxe
Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Neuroscience 1996;72(1):89-97.
1996: Michele Morari; WT O'Connor; M Darvelid; U Ungerstedt; C Bianchi; Kjell Fuxe
Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--I. Effects of perfusion with tetrodotoxin and low-calcium medium.
Neuroscience 1996;72(1):79-87.
1995: Clementina Bianchi; Luca Ferraro; Sergio Tanganelli; Michele Morari; G Spalluto; Michele Simonato; Lorenzo Beani
5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices.
British journal of pharmacology 1995;116(6):2724-8.
1995: Michele Morari; Girolamo Calo; Luca Ferraro; A Fabrizi; Nicola Acciarri; G Piazza; Clementina Bianchi; Lorenzo Beani
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices.
Neurochemistry international 1995;26(1):77-83.
1994: Michele Morari; WT O'Connor; U Ungerstedt; Kjell Fuxe
Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid.
European journal of pharmacology 1994;256(1):23-30.
1994: Michele Morari; M Menegale; G Caló; Luca Ferraro; C Tomasini; Clementina Bianchi; Lorenzo Beani
Excitatory amino acids (EAAs) stimulate phosphatidylinositol turnover in adult rat striatal slices: interaction between NMDA and EAA metabotropic receptors.
Neurochemistry international 1994;24(2):191-200.
1993: Michele Morari; WT O'Connor; U Ungerstedt; Kjell Fuxe
N-methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: an in vivo microdialysis study.
Journal of neurochemistry 1993;60(5):1884-93.
1992: Lorenzo Beani; Clementina Bianchi; Tiziana Antonelli; G Caló; Michele Morari; V Ferioli; G Gaist
Comparison of [3H]choline and D-[3H]aspartate efflux from guinea pig and human neocortex.
Journal of neurochemistry 1992;58(4):1454-9.
1992: Kjell Fuxe; A M Janson; L Rosén; UB Finnman; Sergio Tanganelli; Michele Morari; M Goldstein; Luigi F Agnati
Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1992;88(1):117-30.
1991: Tiziana Antonelli; Michele Morari; A Magri; Clementina Bianchi
Effect of alpha-adrenoreceptors in the control of spontaneous motility and morphine withdrawal syndrome.
Bollettino della Società italiana di biologia sperimentale 1991;67(10-11):965-71.
1991: Lorenzo Beani; Sergio Tanganelli; Tiziana Antonelli; Luca Ferraro; Michele Morari; P Spalluto; agneta nordberg; Clementina Bianchi
Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]-D-aspartate and endogenous GABA in freely moving guinea-pigs.
British journal of pharmacology 1991;104(1):15-20.
1991: Lorenzo Beani; Clementina Bianchi; Luca Ferraro; Michele Morari; Michele Simonato; G Spalluto; Sergio Tanganelli
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance.
The Journal of pharmacology and experimental therapeutics 1991;258(2):472-6.
1991: Michele Morari; Girolamo Calo; Tiziana Antonelli; G Gaist; Nicola Acciarri; A Fabrizi; Clementina Bianchi; Lorenzo Beani
Inhibitory effect of NMDA receptor activation on quisqualate-stimulated phosphatidylinositol turnover in the human cerebral cortex.
Brain research 1991;553(1):14-7.
1991: Severo Salvadori; Mauro Marastoni; Gianfranco Balboni; Pier Andrea Borea; Michele Morari; Roberto Tomatis
Synthesis and structure-activity relationships of deltorphin analogues.
Journal of medicinal chemistry 1991;34(5):1656-61.
1991: Sergio Tanganelli; Tiziana Antonelli; Michele Morari; Clementina Bianchi; Lorenzo Beani
Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs.
Neuroscience letters 1991;122(2):270-2.
1989: P Spalluto; Michele Morari; Luca Ferraro; agneta nordberg; Tiziana Antonelli; Sergio Tanganelli; Clementina Bianchi; Lorenzo Beani
Effect of (-)nicotine on GABA efflux from guinea pig cerebral cortex slices.
Pharmacological research : the official journal of the Italian Pharmacological Society 1989;21 Suppl 1():133-4.